155 related articles for article (PubMed ID: 36912284)
21. BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia.
Roohollahi K; de Jong Y; Pai G; Zaini MA; de Lint K; Sie D; Rooimans MA; Rockx D; Hoskins EE; Ameziane N; Wolthuis R; Joenje H; Wells SI; Dorsman J
Sci Rep; 2022 Jan; 12(1):45. PubMed ID: 34997070
[TBL] [Abstract][Full Text] [Related]
22. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia.
Kutler DI; Auerbach AD; Satagopan J; Giampietro PF; Batish SD; Huvos AG; Goberdhan A; Shah JP; Singh B
Arch Otolaryngol Head Neck Surg; 2003 Jan; 129(1):106-12. PubMed ID: 12525204
[TBL] [Abstract][Full Text] [Related]
23. Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer.
Webster ALH; Sanders MA; Patel K; Dietrich R; Noonan RJ; Lach FP; White RR; Goldfarb A; Hadi K; Edwards MM; Donovan FX; Hoogenboezem RM; Jung M; Sridhar S; Wiley TF; Fedrigo O; Tian H; Rosiene J; Heineman T; Kennedy JA; Bean L; Rosti RO; Tryon R; Gonzalez AM; Rosenberg A; Luo JD; Carroll TS; Shroff S; Beaumont M; Velleuer E; Rastatter JC; Wells SI; Surrallés J; Bagby G; MacMillan ML; Wagner JE; Cancio M; Boulad F; Scognamiglio T; Vaughan R; Beaumont KG; Koren A; Imielinski M; Chandrasekharappa SC; Auerbach AD; Singh B; Kutler DI; Campbell PJ; Smogorzewska A
Nature; 2022 Dec; 612(7940):495-502. PubMed ID: 36450981
[TBL] [Abstract][Full Text] [Related]
24. Management of Fanconi Anemia patients with head and neck carcinoma: Diagnosis and treatment adaptation.
Beddok A; Krieger S; Castera L; Stoppa-Lyonnet D; Thariat J
Oral Oncol; 2020 Sep; 108():104816. PubMed ID: 32480311
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of the tumor suppressor genes causing the hereditary syndromes predisposing to head and neck cancer via promoter hypermethylation in sporadic head and neck cancers.
Smith IM; Mithani SK; Mydlarz WK; Chang SS; Califano JA
ORL J Otorhinolaryngol Relat Spec; 2010; 72(1):44-50. PubMed ID: 20332657
[TBL] [Abstract][Full Text] [Related]
26. Fanconi anaemia: A syndrome with distinct subgroups.
Alter BP; Giri N; McReynolds LJ; Altintas B
Br J Haematol; 2022 May; 197(4):467-474. PubMed ID: 35191533
[TBL] [Abstract][Full Text] [Related]
27. Natural history and management of Fanconi anemia patients with head and neck cancer: A 10-year follow-up.
Kutler DI; Patel KR; Auerbach AD; Kennedy J; Lach FP; Sanborn E; Cohen MA; Kuhel WI; Smogorzewska A
Laryngoscope; 2016 Apr; 126(4):870-9. PubMed ID: 26484938
[TBL] [Abstract][Full Text] [Related]
28. The fanconi anemia pathway limits human papillomavirus replication.
Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI
J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo inhibition of human Fanconi anemia-associated head and neck squamous cell carcinoma by a novel nutrient mixture.
Roomi MW; Kalinovsky T; Roomi NW; Niedzwiecki A; Rath M
Int J Oncol; 2012 Dec; 41(6):1996-2004. PubMed ID: 23007964
[TBL] [Abstract][Full Text] [Related]
30. The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.
Romick-Rosendale LE; Lui VWY; Grandis JR; Wells SI
Mutat Res; 2013; 743-744():78-88. PubMed ID: 23333482
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo inhibition of human Fanconi anemia head and neck squamous carcinoma by a phytonutrient combination.
Roomi MW; Kalinovsky T; Roomi NW; Niedzwiecki A; Rath M
Int J Oncol; 2015 May; 46(5):2261-6. PubMed ID: 25695860
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive molecular screening for oral precancer in Fanconi anemia patients.
Smetsers SE; Velleuer E; Dietrich R; Wu T; Brink A; Buijze M; Deeg DJ; Soulier J; Leemans CR; Braakhuis BJ; Brakenhoff RH
Cancer Prev Res (Phila); 2015 Nov; 8(11):1102-11. PubMed ID: 26276748
[TBL] [Abstract][Full Text] [Related]
33. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
[TBL] [Abstract][Full Text] [Related]
34. Association of human papillomavirus with Fanconi anemia promotes carcinogenesis in Fanconi anemia patients.
Liu GB; Chen J; Wu ZH; Zhao KN
Rev Med Virol; 2015 Nov; 25(6):345-53. PubMed ID: 25776992
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Fanconi Anemia Patients with Head and Neck Squamous Cell Carcinoma: Israel Fanconi Registry.
Tsur N; Frig O; Steinberg-Shemer O; Tamary H; Kurman N; Mizrachi A; Popovtzer A
Isr Med Assoc J; 2022 Aug; 24(8):491-496. PubMed ID: 35971997
[TBL] [Abstract][Full Text] [Related]
36. Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells.
Zhao X; Brusadelli MG; Sauter S; Butsch Kovacic M; Zhang W; Romick-Rosendale LE; Lambert PF; Setchell KDR; Wells SI
Clin Cancer Res; 2018 Jun; 24(11):2700-2709. PubMed ID: 29530934
[No Abstract] [Full Text] [Related]
37. Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments.
Kachnic LA; Li L; Fournier L; Willers H
Cancer Lett; 2010 Jun; 292(1):73-9. PubMed ID: 20034732
[TBL] [Abstract][Full Text] [Related]
38. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
Errazquin R; Page A; Suñol A; Segrelles C; Carrasco E; Peral J; Garrido-Aranda A; Del Marro S; Ortiz J; Lorz C; Minguillon J; Surralles J; Belendez C; Alvarez M; Balmaña J; Bravo A; Ramirez A; Garcia-Escudero R
Oral Oncol; 2022 Nov; 134():106184. PubMed ID: 36191479
[TBL] [Abstract][Full Text] [Related]
39. Chromosome fragility in the buccal epithelium in patients with Fanconi anemia.
Ramírez MJ; Minguillón J; Loveless S; Lake K; Carrasco E; Stjepanovic N; Balmaña J; Català A; Mehta PA; Surrallés J
Cancer Lett; 2020 Mar; 472():1-7. PubMed ID: 31830560
[TBL] [Abstract][Full Text] [Related]
40. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
